IZOZF Izotropic Corporation
Izotropic Corporation (IZOZF) is expected to report earnings on December 28, 2026, during market hours. The consensus earnings estimate is $0.01 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -29.0% since its last earnings release on September 28, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Izotropic Corporation
Izotropic Corporation is a medical device company commercializing imaging-based products for the more accurate screening, diagnoses and treatment of breast cancers. Izotropic Corporation is based in NEW YORK.
Charts powered in part by Lightweight Charts™ by TradingView.